Human Steroid Biosynthesis

Knobil and Neill's Physiology of Reproduction: Two-Volume Set

Volumn 1, Issue , 2015, Pages 295-312

  Auchus, Richard J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adrenal cortex; Androgen; Cytochrome P450; Estrogen; Gonads; Hydroxysteroid dehydrogenase; Progestin; Steroidogenesis

Indexed keywords

EID: 84942925161     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-397175-3.00008-9     Document Type: Chapter

References (108)

1. Jailer J.W., Gold J.J., Vande Wiele R., Lieberman S. 17α-hydroxyprogesterone and 21-desoxyhydrocortisone, their metabolism and possible role in congenital adrenal virilism. J Clin Invest 1955, 34:1639-1646.
2. Bongiovanni A.M., Eberlein W.R. Plasma and urinary corticosteroids in the hypertensive form of congenital adrenal hyperplasia. J Biol Chem 1956, 223:85-94.
3. Bongiovanni A.M. The adrenogenital syndrome with deficiency of 3β-hydroxysteroid dehydrogenase. J Clin Invest 1962, 41:2086.
4. Cooper D.Y., Levin S., Narasimhulu S., Rosenthal O., Estabrook R.W. Photochemical action spectrum of the terminal oxidase of mixed function oxidase systems. Science 1965, 147:400-402.
5. Lu A.Y., Junk K.W., Coon M.J. Resolution of the cytochrome P-450-containing omega-hydroxylation system of liver microsomes into three components. J Biol Chem 1969, 244:3714-3721.
6. Nakajin S., Shively J.E., Yuan P., Hall P.F. Microsomal cytochrome P450 from neonatal pig testis: two enzymatic activities (17α-hydroxylase and C17,20-lyase) associated with one protein. Biochemistry 1981, 20:4037-4042.
7. 21 side-chain cleavage). Biochem Biophys Res Commun 1982, 108:454-460.
8. Zuber M.X., Simpson E.R., Waterman M.R. Expression of bovine 17α-hydroxylase cytochrome P450 cDNA in non-steroidogenic (COS-1) cells. Science 1986, 234:1258-1261.
9. Miller W.L. Molecular biology of steroid hormone synthesis. Endocr Rev 1988, 9:295-318.
10. 4 isomerase gene family. Endocr Rev 2005, 26:525-582.
11. Labrie F., Luu-The V., Lin S.X., et al. The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology. Steroids 1997, 62:148-158.
12. Ghosh D., Wawrzak Z., Weeks C.M., Duax W.L., Erman M. The refined three-dimensional structure of 3α, 20β-hydroxysteroid dehydrogenase and possible roles of the residues conserved in short-chain dehydrogenases. Structure 1994, 2:629-640.
13. Ghosh D., Pletnev V.Z., Zhu D.W., et al. Structure of human estrogenic 17β-hydroxysteroid dehydrogenase at 2.20Å resolution. Structure 1995, 3:503-513.
14. Hoog S.S., Pawlowski J.E., Alzari P.M., Penning T.M., Lewis M. Three-dimensional structure of rat liver 3α-hydroxysteroid/dihydrodiol dehydrogenase: a member of the aldo-keto reductase superfamily. Proc Natl Acad Sci USA 1994, 91:2517-2521.
15. Arlt W., Walker E.A., Draper N., et al. Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 2004, 363:2128-2135.
16. Flück C.E., Tajima T., Pandey A.V., et al. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 2004, 36:228-230.
17. Miller W.L., Auchus R.J. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011, 32:81-151.
18. Miller W.L. A brief history of adrenal research: steroidogenesis - the soul of the adrenal. Mol Cell Endocrinol 2013, 371:5-12.
19. 4-3-ketosteroid 5β-reductase (AKR1D1) and implications for substrate binding and catalysis. J Biol Chem 2008, 283:16830-16839.
20. Khan N., Sharma K.K., Andersson S., Auchus R.J. Human 17β-hydroxysteroid dehydrogenases types 1, 2, and 3 catalyze bi-directional equilibrium reactions, rather than unidirectional metabolism, in HEK-293 cells. Arch Biochem Biophys 2004, 429:50-59.
21. Mizrachi D., Auchus R.J. Androgens, estrogens, and hydroxysteroid dehydrogenases. Mol Cell Endocrinol 2009, 301:37-42.
22. Clark B.J., Wells J., King S.R., Stocco D.M. The purification, cloning and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem 1994, 269:28314-28322.
23. Lin D., Sugawara T., Strauss J.F., et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995, 267:1828-1831.
24. Arakane F., King S.R., Du Y., et al. Phosphorylation of steroidogenic acute regulatory protein (StAR) modulates its steroidogenic activity. J Biol Chem 1997, 272:32656-32662.
25. Bose H., Lingappa V.R., Miller W.L. Rapid regulation of steroido-genesis by mitochondrial protein import. Nature 2002, 417:87-91.
26. Tsujishita Y., Hurley J.H. Structure and lipid transport mechanism of a StAR-related domain. Nat Struct Biol 2000, 7:408-414.
27. Strushkevich N., MacKenzie F., Cherkesova T., Grabovec I., Usanov S., Park H.W. Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system. Proc Natl Acad Sci USA 2011, 108:10139-10143.
28. Lifton R., Dluhy R.G., Powers M., et al. A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992, 335:262-265.
29. Strushkevich N., Gilep A.A., Shen L., et al. Structural insights into aldosterone synthase substrate specificity and targeted inhibition. Mol Endocrinol 2013, 27:315-324.
30. Chung B.C., Picado-Leonard J., Haniu M., et al. Cytochrome P450c17 (steroid 17α-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc Natl Acad Sci USA 1987, 84:407-411.
31. 21 steroids are substrates for human cytochrome P450c17. Arch Biochem Biophys 2003, 418:151-160.
32. Swart P., Swart A.C., Waterman M.R., Estabrook R.W., Mason J.I. Progesterone 16α-hydroxylase activity is catalyzed by human cytochrome P450 17α-hydroxylase. J Clin Endocrinol Metab 1993, 77:98-102.
33. Swart A.C., Storbeck K.H., Swart P. A single amino acid residue, Ala 105, confers 16α-hydroxylase activity to human cytochrome P450 17α-hydroxylase/17,20 lyase. J Steroid Biochem Mol Biol 2010, 119:112-120.
34. Yoshimoto F.K., Zhou Y., Peng H.M., et al. Minor activities and transition state properties of the human steroid hydroxylases cytochromes P450c17 and P450c21, from reactions observed with deuterium-labeled substrates. Biochemistry 2012, 51:7064-7077.
35. 5 augments the 17,20 lyase activity of human P450c17 without direct electron transfer. J Biol Chem 1998, 273:3158-3165.
36. 5 steroidogenic pathway. J Clin Endocrinol Metab 2003, 88:3762-3766.
37. Geller D.H., Auchus R.J., Mendonça B.B., Miller W.L. The genetic and functional basis of isolated 17,20 lyase deficiency. Nature Genet 1997, 17:201-205.
38. Sherbet D.P., Tiosano D., Kwist K.M., Hochberg Z., Auchus R.J. CYP17 mutation E305G causes isolated 17,20-lyase deficiency by selectively altering substrate binding. J Biol Chem 2003, 278:48563-48569.
39. Hershkovitz E., Parvari R., Wudy S.A., et al. Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17,20-lyase deficiency. J Clin Endocrinol Metab 2008, 93:3584-3588.
40. 5 on both CYP2E1 and CYP2C19 activities requires the anionic residues D58 and D65. Biochemistry 2013, 52:210-220.
41. Pandey A.V., Mellon S.H., Miller W.L. Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17. J Biol Chem 2003, 278:2837-2844.
42. 5 and by serine phosphorylation of P450c17. J Biol Chem 2005, 280:13265-13271.
43. 5 in the biosynthesis of androgens by human P450c17. Arch Biochem Biophys 1995, 317:343-347.
44. 5 gene causes 46, XY disorder of sex development due to true isolated 17,20 lyase deficiency. J Clin Endocrinol Metab 2012, 97:E465-E475.
45. 5 mutation W27X. J Clin Endocrinol Metab 2010, 95:994-999.
46. 5 requires residues E48 and E49 to stimulate the 17,20-lyase activity of cytochrome P450c17. Biochemistry 2006, 45:755-762.
47. 21 side-chain cleavage from pig testis. Biochem Biophys Res Commun 1985, 132:708-713.
48. Mizrachi D., Wang Z., Sharma K.K., et al. Why human cytochrome P450c21 is a progesterone 21-hydroxylase. Biochemistry 2011, 50:3968-3974.
49. Therrell B.L.J., Berenbaum S.A., Manter-Kapanke V., et al. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 1998, 101:583-590.
50. White P.C., Speiser P.W. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000, 21:245-291.
51. Simpson E.R., Mahendroo M.S., Means G.D., et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 1994, 15:342-355.
52. Ghosh D., Griswold J., Erman M., Pangborn W. Structural basis for androgen specificity and oestrogen synthesis in human aromatase. Nature 2009, 457:219-223.
53. DeVore N.M., Scott E.E. Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001. Nature 2012, 482:116-119.
54. de Bono J.S., Logothetis C.J., Molina A., et al. Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 2011, 364:1995-2005.
55. Ryan C.J., Smith M.R., de Bono J.S., et al. Abiraterone in metastatic prostate cancer without previous chemotherapy. N Engl J Med 2013, 368:138-148.
56. Zhao B., Lei L., Kagawa N., et al. A three-dimensional structure of steroid 21-hydroxylase (Cytochrome P450 21A2) with two substrates reveals locations of disease-associated variants. J Biol Chem 2012, 287:10613-10622.
57. Agarwal A.K., Auchus R.J. Minireview: cellular redox state regulates hydroxysteroid dehydrogenase activity and intracellular hormone potency. Endocrinology 2005, 146:2531-2538.
58. Sherbet D.P., Guryev O.L., Papari-Zareei M., et al. Biochemical factors governing the steady-state estrone/estradiol ratios catalyzed by human 17β-hydroxysteroid dehydrogenases types 1 and 2 in HEK-293 cells. Endocrinology 2009, 150:4154-4162.
59. Ratnam K., Ma H., Penning T.M. The arginine 276 anchor for NADP(H) dictates fluorescence kinetic transients in 3α-hydroxysteroid dehydrogenase, a representative aldo-keto reductase. Biochemistry 1999, 38:7856-7864.
60. Papari-Zareei M., Brandmaier A., Auchus R.J. Arginine 276 controls the directional preference of AKR1C9 (rat liver 3α-hydroxysteroid dehydrogenase) in human embryonic kidney 293 cells. Endocrinology 2006, 147:1591-1597.
61. Wu L., Einstein M., Geissler W.M., Chan H.K., Ellison K.O., Andersson S. Expression cloning and characterization of human 17β-hydrosteroid dehydrogenase type 2, a microsomal enzyme possessing 20α-hydroxysteroid dehydrogenase activity. J Biol Chem 1993, 268:12964-12969.
62. Tomlinson J.W., Walker E.A., Bujalska I.J., et al. 11β-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 2004, 25:831-866.
63. Bujalska I.J., Draper N., Michailidou Z., et al. Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11β-hydroxysteroid dehydrogenase type 1. J Mol Endocrinol 2005, 34:675-684.
64. Walker E.A., Clark A.M., Hewison M., Ride J.P., Stewart P.M. Functional expression, characterization, and purification of the catalytic domain of human 11β-hydroxysteroid dehydrogenase type 1. J Biol Chem 2001, 276:21343-21350.
65. Lawson A.J., Walker E.A., Lavery G.G., et al. Cortisone-reductase deficiency associated with heterozygous mutations in 11β-hydroxysteroid dehydrogenase type 1. Proc Natl Acad Sci USA 2011, 108:4111-4116.
66. Draper N., Walker E.A., Bujalska I.J., et al. Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet 2003, 34:434-439.
67. Lavery G.G., Walker E.A., Tiganescu A., et al. Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency. J Clin Endocrinol Metab 2008, 93:3827-3832.
68. White P.C., Mune T., Agarwal A.K. 11β-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 1997, 18:135-156.
69. Geissler W.M., Davis D.L., Wu L., et al. Male pseudohermaphroiditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3. Nature Genet 1994, 7:34-39.
70. Flück C.E., Meyer-Boni M., Pandey A.V., et al. Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation. Am J Hum Genet 2011, 89:201-218.
71. Jin Y., Penning T.M. Multiple steps determine the overall rate of the reduction of 5α-dihydrotestosterone catalyzed by human type 3 3α-hydroxysteroid dehydrogenase: implications for the elimination of androgens. Biochemistry 2006, 45:13054-13063.
72. Heredia V.V., Penning T.M. Dissection of the physiological interconversion of 5α-DHT and 3α-diol by rat 3α-HSD via transient kinetics shows that the chemical step is rate-determining: effect of mutating cofactor and substrate-binding pocket residues on catalysis. Biochemistry 2004, 43:12028-12037.
73. 4 isomerase deficiency. Semin Reprod Med 2002, 20:255-276.
74. Lee T.C., Miller W.L., Auchus R.J. Medroxyprogesterone acetate and dexamethasone are competitive inhibitors of different human steroidogenic enzymes. J Clin Endocrinol Metab 1999, 84:2104-2110.
75. Thomas J.L., Mason J.I., Brandt S., Spencer B.R., Norris W. Structure/function relationships responsible for the kinetic differences between human type 1 and type 2 3β-hydroxysteroid dehydrogenase and for the catalysis of the type 1 activity. J Biol Chem 2002, 277:42795-42801.
76. Arlt W., Justl H.-G., Callies F., et al. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab 1998, 83:1928-1934.
77. Hammer F., Subtil S., Lux P., et al. No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: in vivo and in vitro studies. J Clin Endocrinol Metab 2005, 90:3600-3605.
78. Noordam C., Dhir V., McNelis J.C., et al. Inactivating PAPSS2 mutations in a patient with premature pubarche. N Engl J Med 2009, 360:2310-2318.
79. Wilson J.D., Griffin J.E., Russell D.W. Steroid 5α-reductase 2 deficiency. Endocr Rev 1993, 14:577-593.
80. Fisher M.B., Paine M.F., Strelevitz T.J., Wrighton S.A. The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metab Rev 2001, 33:273-297.
81. Girard C., Barbier O., Veilleux G., El-Alfy M., Belanger A. Human uridine diphosphate-glucuronosyltransferase UGT2B7 conjugates mineralocorticoid and glucocorticoid metabolites. Endocrinology 2003, 144:2659-2668.
82. Turgeon D., Carrier J.S., Levesque E., Hum D.W., Belanger A. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 2001, 142:778-787.
83. Jakobsson J., Ekström L., Inotsume N., et al. Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. J Clin Endocrinol Metab 2006, 91:687-693.
84. Wilson W., Pardo-Manuel de Villena F., Lyn-Cook B.D., et al. Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15. Genomics 2004, 84:707-714.
85. Schulze J.J., Lundmark J., Garle M., Skilving I., Ekström L., Rane A. Doping test results dependent on genotype of UGT2B17, the major enzyme for testosterone glucuronidation. J Clin Endocrinol Metab 2008, 93:2500-2506.
86. Gomes L.G., Huang N., Agrawal V., Mendonça B.B., Bachega T.A., Miller W.L. Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency. J Clin Endocrinol Metab 2009, 94:89-95.
87. Chortis V., Taylor A.E., Schneider P., et al. Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement. J Clin Endocrinol Metab 2013, 98:161-171.
88. Bassett M.H., Suzuki T., Sasano H., White P.C., Rainey W.E. The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production. Mol Endocrinol 2004, 18:279-290.
89. Mulatero P., Curnow K.M., Aupetit-Faisant B., et al. Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol. J Clin Endocrinol Metab 1998, 83:3996-4001.
90. Costa-Santos M., Kater C.E., Auchus R.J. Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency. J Clin Endocrinol Metab 2004, 89:49-60.
91. Minutti C.Z., Lacey J.M., Magera M.J., et al. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 2004, 89:3687-3693.
92. Tonetto-Fernandes V., Lemos-Marini S.H., Kuperman H., Ribeiro-Neto L.M., Verreschi I.T., Kater C.E. Serum 21-deoxycortisol, 17-hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11β-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency. J Clin Endocrinol Metab 2006, 91:2179-2184.
93. Suzuki T., Sasano H., Takeyama J., et al. Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies. Clin Endocrinol (Oxf) 2000, 53:739-747.
94. Nakamura Y., Hornsby P.J., Casson P., et al. Type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis. J Clin Endocrinol Metab 2009, 94:2192-2198.
95. Hillier S.G., Yong E.L., Illingworth P.J., Baird D.T., Schwall R.H., Mason A.J. Effect of recombinant activin on androgen synthesis in cultured human thecal cells. J Clin Endocrinol Metab 1991, 72:1206-1211.
96. Auchus R.J. The backdoor pathway to dihydrotestosterone. Trends Endocrinol Metab 2004, 15:432-438.
97. Wilson J.D., Auchus R.J., Leihy M.W., et al. 5α-androstane-3α,17β-diol is formed in tammar wallaby pouch young testes by a pathway involving 5α-pregnane-3α,17α-diol-20-one as a key intermediate. Endocrinology 2003, 144:575-580.
98. Homma K., Hasegawa T., Nagai T., et al. Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone. J Clin Endocrinol Metab 2006, 91:2643-2649.
99. Kamrath C., Hochberg Z., Hartmann M.F., Remer T., Wudy S.A. Increased activation of the alternative "backdoor" pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis. J Clin Endocrinol Metab 2012, 97:E367-E375.
100. Chang K.H., Li R., Papari-Zareei M., et al. Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer. Proc Natl Acad Sci USA 2011, 108:13728-13733.
101. Cutler G.B., Glenn M., Bush M., Hodgen G.D., Graham C.E., Loriaux D.L. Adrenarche: a survey of rodents, domestic animals and primates. Endocrinology 1978, 103:2112-2118.
102. 5-steroid-17,20-lyase reactions. Mol Endocrinol 1989, 3:968-975.
103. 5-lyase activity of rat CYP17. J Biol Chem 1993, 268:18267-18271.
104. 21-steroid biosynthesis in the fish ovary and head kidney. Endocrinology 2007, 148:4282-4291.
105. Payne A.H., Abbaszade I.G., Clarke T.R., Bain P.A., Park C.H.J. The multiple murine 3β-hydroxysteroid dehydrogenase isoforms: structure, function, and tissue- and developmentally specific expression. Steroids 1997, 62:169-175.
106. Labrie F., Luu-The V., Lin S.X., Simard J., Labrie C. Role of 17β-hydroxysteroid dehydrogenases in sex steroid formation in peripheral intracrine tissues. Trends Endocrinol Metab 2000, 11:421-427.
107. Yang X., Iwamoto K., Wang M., Artwohl J., Mason J.I., Pang S. Inherited congenital adrenal hyperplasia in the rabbit is caused by a deletion in the gene encoding cytochrome P450 cholesterol side-chain cleavage enzyme. Endocrinology 1993, 132:1977-1982.
108. Mason J.I., France J.T., Magness R.R., Murry B.A., Rosenfeld C.R. Ovine placental steroid 17α-hydroxylase/C-17,20-lyase, aromatase and sulphatase in dexamethasone-induced and natural parturit0ion. J Endocrinol 1989, 122:351-359.